Eurolens Research
Manchester, United Kingdom
NCT Number: NCT05741450
The study objective was to gather short-term clinical performance data for two soft contact lenses.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Manchester, United Kingdom
The aim of this subject-masked, non-randomized, controlled non-dispensing study was to evaluate the short-term clinical performance of a monthly sphere contact lens when compared to a daily disposable contact lens after 15 minutes of daily wear each.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monthly replacement spherical silicone hydrogel contact lens for 15 minutes
Daily disposable spherical silicone hydrogel contact lens for 15 minutes
Time frame: 15 minutes
Subjective overall score was assessed using 0-100 visual analogue scale, where 0=Extremely poor, cannot use lenses and 100=Excellent, highly impressed with these lenses overall
Time frame: 15 minutes
Subjective comfort score was assessed using 0-100 visual analogue scale, where 0=Causes pain, cannot be tolerated and 100=Excellent, cannot be felt
Time frame: 15 minutes
Subjective vision score was assessed using a 0-100 visual analogue scale, where 0=Unacceptable, lens cannot be worn and 100=Excellent, unaware of any visual loss
CooperVision, Inc.
Industry
A Clinical Comparison of Two Soft Contact Lenses (Iteration Under Umbrella Protocol C19-678)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06758076
Eye Diseases, Hyperopia
Manchester, United Kingdom
View Trial DetailsNCT06869044
Eye Diseases, Hyperopia
Berkeley, California, United States
View Trial DetailsNCT07276347
Eye Diseases, Hyperopia
Bloomington, Indiana, United States
View Trial DetailsNCT06873048
Astigmatism, Eye Diseases
Waterloo, Ontario, Canada
View Trial Details